5-溴-2-(哌啶-1-)吡啶 | 24255-95-6

• 物质功能分类: 医药中间体 - 杂环化合物 - 吡啶类化合物
• 分子结构分类: 有机化合物 - 有机氮化合物
• 中文名称: 5-溴-2-(哌啶-1-)吡啶
• 中文别名: 5-溴-2-(哌啶-1-基)吡啶
• 英文名称: 5-bromo-2-(piperidin-1-yl)pyridine
• 英文别名: 5-bromo-2-piperidin-1-ylpyridine
• CAS: 24255-95-6
• 化学式: C₁₀H₁₃BrN₂
• 分子量: 241.131
• InChiKey: AEDSMUUEBQNEAA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  16.1
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 危险品标志：
  Xn,Xi
• 海关编码：
  2933990090

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 5-Bromo-2-(piperidin-1-yl)pyridine
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 5-Bromo-2-(piperidin-1-yl)pyridine
CAS number: 24255-95-6

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C10H13BrN2
Molecular weight: 241.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  5-溴-2-(哌啶-1-)吡啶 在 bis-triphenylphosphine-palladium(II) chloride 哌啶 、 copper(l) iodide 、 potassium carbonate 、 三乙胺 作用下， 以 四氢呋喃 、 甲醇 、 乙腈 为溶剂， 反应 73.0h， 生成 5-(4-Chlorophenyl)-6-[2-(6-piperidin-1-ylpyridin-3-yl)ethynyl]pyrimidin-4-amine
  参考文献：
  名称：

  4-Amino-5-aryl-6-arylethynylpyrimidines: Structure–activity relationships of non-nucleoside adenosine kinase inhibitors

  摘要：

  A series of non-nucleoside adenosine kinase (AK) inhibitors is reported. These inhibitors originated from the modification of 5-(3-bromophenyl)-7-(6-morpholin-4-ylpyridin-3-yl)pyrido[2,3-d]pyrimidin-4-ylamine (ABT-702). The identification of a linker that would approximate the spatial arrangement found between the pyrimidine ring and the aryl group at C(7) in ABT702 was a key element in this modification. A search of potential linkers led to the discovery of an acetylene moiety as a suitable scaffold. It was hypothesized that the aryl acetylenes, ABT-702, and adenosine bound to the active site of AK (closed form) in a similar manner with respect to the orientation of the heterocyclic base. Although potent acetylene analogs were discovered based on this assumption, an X-ray crystal structure of 5-(4-dimethylaminophenyl)-6-(6-morpholin-4-yipyridin-3-ylethynyl)pyrimidin-4-ylamine (16a) revealed a binding orientation contrary to adenosine. In addition, this compound bound tightly to a unique open conformation of AK. The structure-activity relationships and unique ligand orientation and protein conformation are discussed. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2006.12.029
• 作为产物：
  描述：

  哌啶 、 5-溴-2-氯吡啶 在 1,1'-bis[bis(dimethylamino)phosphino]ferrocene 、 bis(dibenzylideneacetone)-palladium⁽⁰⁾ 、 sodium t-butanolate 作用下， 以 1,4-二氧六环 为溶剂， 反应 15.0h， 以47%的产率得到5-溴-2-(哌啶-1-)吡啶
  参考文献：
  名称：

  与多卤代吡啶在Pd催化的胺化中反转常规化学选择性

  摘要：

  报道了一种能够在Pd催化的3,2-和5,2- Br / Cl-吡啶的胺化反应中实现选择性氯化物官能化的新型催化剂体系。利用配体参数化的反应优化策略导致鉴定出1,1'-双[双（二（二甲基氨基）膦基]二茂铁“ DMAPF”，一种易于获得但尚未使用的二膦，作为该转化的独特有效配体。

  DOI：

  10.1021/jacs.7b05409

文献信息

• Ni-Catalyzed Reductive Cyanation of Aryl Halides and Phenol Derivatives via Transnitrilation
  作者：L. Reginald Mills、Joshua M. Graham、Purvish Patel、Sophie A. L. Rousseaux

  DOI：10.1021/jacs.9b11208

  日期：2019.12.11

  reductive coupling for the synthesis of benzonitriles from aryl (pseudo)halides and an electrophilic cyanating reagent, 2-methyl-2-phenyl malononitrile (MPMN). MPMN is a bench-stable, carbon-bound electrophilic CN reagent that does not release cyanide under the reaction conditions. A variety of medicinally relevant benzonitriles can be made in good yields. Addition of NaBr to the reaction mixture allows for

  在此，我们报告了一种 Ni 催化的还原偶联，用于从芳基（伪）卤化物和亲电氰化试剂 2-甲基-2-苯基丙二腈 (MPMN) 合成苯甲腈。MPMN 是一种工作台稳定的碳键合亲电子 CN 试剂，在反应条件下不会释放氰化物。可以以良好的收率制备多种与药用相关的苯甲腈。将 NaBr 添加到反应混合物中可以使用更具挑战性的芳基亲电试剂，例如芳基氯化物、甲苯磺酸盐和三氟甲磺酸盐。机理研究表明，溴化钠在促进这些底物的氧化加成方面发挥作用。
• Catalytic Arylboration of Spirocyclic Cyclobutenes: Rapid Access to Highly Substituted Spiro[3.n]alkanes
  作者：Amit Kumar Simlandy、Mao-Yun Lyu、M. Kevin Brown

  DOI：10.1021/acscatal.1c03491

  日期：2021.10.15

  A method to achieve the synthesis of highly substituted spirocyclic cyclobutanes is disclosed. The reaction involves the catalytic arylboration of cyclobutenes. Depending on the substitution pattern of the cyclobutene, either a Cu/Pd- or a Ni-catalyzed reaction was utilized. In the case of the Cu/Pd-catalyzed reactions, the identification of a Cu-complex for arylboration was crucial to observe high

  公开了一种合成高度取代的螺环环丁烷的方法。该反应涉及环丁烯的催化芳基硼化。根据环丁烯的取代模式，使用 Cu/Pd 或 Ni 催化反应。在铜/钯催化反应的情况下，鉴定用于芳基硼化的铜络合物对于观察高选择性至关重要。展示了产品的合成效用，并讨论了机械细节。
• PDE 10a Inhibitors for the Treatment of Type II Diabetes
  申请人：Janssen Pharmaceutica, NV

  公开号：US20140364414A1

  公开（公告）日：2014-12-11

  Disclosed are compounds, compositions and methods for treating Type II diabetes. Such compounds are represented by Formula (I) as follows: wherein R 1 , R 2 , L, and Q are defined herein.

  揭示了用于治疗2型糖尿病的化合物、组合物和方法。这些化合物由以下式（I）表示： 其中R1、R2、L和Q在此处定义。
• Alkoxy- and amidocarbonylation of functionalised aryl and heteroaryl halides catalysed by a Bedford palladacycle and dppf: a comparison with the primary Pd(ii) precursors (PhCN)2PdCl2 and Pd(OAc)2
  作者：Ian J. S. Fairlamb、Stephanie Grant、Peter McCormack、John Whittall

  DOI：10.1039/b615874a

  日期：——

  The versatility of a Bedford-type palladacycle 1, namely [Pd(µ-Cl)κ2-P,C-P(OC6H2-2,4-tBu2)(OC6H3-2,4-tBu2)2}}2], as a primary Pd source, in combination with the ligand bis-1,1′-(diphenylphosphino)ferrocene (dppf) has been established in carbonylation reactions of aryl and heteroaryl bromides with methanol, piperidine and related nucleophiles. Palladacycle 1 has been compared with other primary Pd sources, e.g. (PhCN)2PdCl2 and Pd(OAc)2. The efficacy of the carbonylation processes appear to be linked to the [Pd] concentration, substrate : catalyst ratio, CO pressure and reaction temperature. In amidocarbonylation, double carbonylation is observed for certain organohalides. In the case of 2,5-dibromopyridine, regioselective amination (Hartwig–Buchwald type) also occurs as a side-reaction.

  一种Bedford型钯环化合物1，即[Pd(µ-Cl)κ2-P,C-P(OC6H2-2,4-tBu2)(OC6H3-2,4-tBu2)2}}2]，作为主要的钯源，其多功能性已在与醇、哌啶及相关亲核试剂的芳基和杂芳基溴化物的羰基化反应中得到证实。钯环化合物1已与其他主要的钯源进行比较，例如(PhCN)2PdCl2和Pd(OAc)2。羰基化过程的有效性似乎与[钯]浓度、底物与催化剂的比例、一氧化碳压力和反应温度有关。在胺羰基化过程中，某些有机卤化物观察到了双羰基化现象。在2,5-二溴吡啶的情况下，还发生了区域选择性氨基化（Hartwig–Buchwald型）的副反应。
• [EN] INDOLES USEFUL IN THE TREATMENT OF INFLAMMATION<br/>[FR] INDOLES UTILISES DANS LE TRAITEMENT D'INFLAMMATIONS
  申请人：BIOLIPOX AB

  公开号：WO2005123673A1

  公开（公告）日：2005-12-29

  There is provided a compound of formula: (I), wherein X, R1, R2, R3, R4, R5 and R6 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of the activity of microsomal prostaglandin E synthase-1 is desired and/or required, and particularly in the treatment of inflammation.

  提供一种化合物，其化学式为：(I)，其中X、R1、R2、R3、R4、R5和R6的含义如描述中所示，以及其药用盐，这些化合物在需要或希望抑制微粒体前列腺素E合成酶-1活性的疾病治疗中非常有用，特别是在炎症治疗中。